- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Congress Deals 3 Blows to the ACA
What we're reading, December 17, 2015: Congress is expected to pass a spending plan that includes 3 changes to the Affordable Care Act; a new analysis estimates 2016 premiums for marketplace plans will increase 11%; and one-third of Americans die from cardiovascular disease.
Republicans are making small progress in their attempt to do away with President Obama’s healthcare law. A spending plan Congress is expected to approve this week includes 3 changes to the Affordable Care Act, including a delay of the Cadillac tax, a suspension of the tax on medical devices, and limits on federal payments to insurers that lose money in the insurance marketplaces, reported The New York Times.
As for the marketplace health plans, the Robert Wood Johnson Foundation reported that monthly premiums for the silver-level plans will increase by more than 11% in 2016. USA Today reported that this increase, coupled with expected higher deductibles, could limit the number of people insured under the Affordable Care Act. The gold plans, which have higher premiums but smaller out-of-pocket costs, will see premiums increase nearly 14%, though deductibles dropped just under 1%.
One-third of Americans die from cardiovascular disease and is the number 1 killer around the world, reported United Press International. However, strides to reduce smoking, increase physical activity, and adjust diets have improved risk factors for cardiovascular disease. Still, 69% of American adults are overweight or obese and one-third say they engage in no physical activity outside of work.
Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk
April 15th 2025Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer a noninvasive method to identify individuals at increased risk of developing overactive bladder.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria
April 15th 2025Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for better management and understanding of the condition.
Read More
Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH
April 15th 2025A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.
Read More
